Over-The-Counter Overdoses Largely Affect Women, the Young
The Japan Times reported this week on data published by the National Center of Neurology
Cannabis News
Cannabis banking in “next six weeks,” chair says (Newsletter: September 7, 2023)
CA & MA psychedelics; Tribal marijuana vote; FL legalization poll; Prohibs narc on Wells Fargo
High Times Unveils Deal with Nasdaq-Listed Lucy Scientific Discovery to Enter Public Market
Celebrating a milestone in its nearly 50-year history of informing readers and bringing cannabis culture
Massachusetts Hits $5 Billion Marijuana Sales Milestone As State Sees Consecutive Record-Breaking Monthly Purchases
Massachusetts retailers have now sold more than $5 billion in adult-use marijuana since the state’s
From Schedule I to Schedule III: The Path to Success?
In a significant development, the U.S. Department of Health and Human Services (HHS) officially recommended
Medical Marijuana Patients See Improved Quality Of Life And Lower Pain, Anxiety And Depression After Three Months Of Use, Study Shows
Patients with chronic health conditions saw significant improvements in overall quality of life and reductions
Marijuana as Schedule III: Woe is Me?
By Hilary Bricken, Principal at Harris Bricken Unless you’ve been living under a rock, you
Building the Future of Cannabis: A Quicker, Smarter Path to Turnkey Grow Facilities
PRESS RELEASE Overlong lead times for cannabis facility construction prolong revenue generation for new start-ups.
Maryland Marijuana Retailers Sell Record $92 Million In Products During State’s Second Month Of Adult-Use Legalization
Marijuana retailers in Maryland broke another record last month, selling nearly $92 million worth of
Reset Pharma Licenses Filament Drug to Combat Demoralization in Cancer Patients
Reset Pharma is specifically honing in on the plight of cancer patients. Filament Health (OTCQB: